Nasus Pharma Ltd - Ordinary Shares (NSRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
NSRX on NYSE
Shares outstanding
9,042,562
Price per share
$7.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
3,241
Total reported value
$21,553
% of total 13F portfolios
0%
Share change
+3,241
Value change
+$21,553
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nasus Pharma Ltd - Ordinary Shares (NSRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Gilboa Udi 21% $14,354,898 1,901,311 Udi Gilboa 30 Sep 2025
Megiddo Dalia 21% $14,260,991 1,888,873 Dr. Dalia Megiddo 30 Sep 2025
Hershman Ronnie 15% $10,445,516 1,383,512 Dr. Ronnie Hershman 30 Sep 2025
Capital Point Ltd. 6.4% 575,129 Capital Point Ltd. 14 Aug 2025

As of 30 Sep 2025, 2 institutional investors reported holding 3,241 shares of Nasus Pharma Ltd - Ordinary Shares (NSRX). This represents 0.04% of the company’s total 9,042,562 outstanding shares.

Institutional Holders of Nasus Pharma Ltd - Ordinary Shares (NSRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,378 $21,759 -$7,897 $9.15 2
2025 Q3 3,241 $21,553 +$21,553 $6.65 2